430 related articles for article (PubMed ID: 18638617)
21. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
22. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
Weber MA; Giles TD
Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
[TBL] [Abstract][Full Text] [Related]
23. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
24. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
25. Use of valsartan in post-myocardial infarction and heart failure patients.
Liu PP; Maggioni A; Velazquez EJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S19-22. PubMed ID: 16986231
[TBL] [Abstract][Full Text] [Related]
26. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
Jennings DL; Taber DJ
Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
[TBL] [Abstract][Full Text] [Related]
27. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
Pitt B
Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
[TBL] [Abstract][Full Text] [Related]
28. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial.
Maione A; Nicolucci A; Craig JC; Tognoni G; Moschetta A; Palasciano G; Pugliese G; Procaccini DA; Gesualdo L; Pellegrini F; Strippoli GF;
J Nephrol; 2007; 20(6):646-55. PubMed ID: 18046666
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
Chrysant SG
Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
[TBL] [Abstract][Full Text] [Related]
30. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
[TBL] [Abstract][Full Text] [Related]
31. Recent update in the management of hypertension.
Lim S
Acta Med Indones; 2007; 39(4):186-91. PubMed ID: 18380058
[TBL] [Abstract][Full Text] [Related]
32. On target to dual block RAS?
Papadopoulos DP; Papademetriou V; Makris TK
Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
[TBL] [Abstract][Full Text] [Related]
33. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
35. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
Hollenberg NK
Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
[TBL] [Abstract][Full Text] [Related]
36. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
[TBL] [Abstract][Full Text] [Related]
37. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Aksnes TA; Flaa A; Strand A; Kjeldsen SE
J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
[TBL] [Abstract][Full Text] [Related]
38. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
Garg S; Narula J; Marelli C; Cesario D
Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
[TBL] [Abstract][Full Text] [Related]
39. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
Karalliedde J; Viberti G
J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
[TBL] [Abstract][Full Text] [Related]
40. Renin inhibition: what are the clinical perspectives?
Hollenberg NK
Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
